Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial penicillin-binding proteins (PBPs), specifically those with transpeptidase activity, are a family of membrane-associated enzymes essential for the biosynthesis of peptidoglycan, the main structural component of bacterial cell walls. They catalyze transglycosylation (polymerization of glycan strands) and transpeptidation (cross-linking peptide side chains) reactions. PBPs are the targets of β-lactam antibiotics, which inhibit their enzymatic function, disrupting cell wall synthesis and leading to bacterial lysis. Most bacteria possess multiple PBP isoforms, which can complicate the development of highly selective inhibitors.
β-Lactam antibiotics bind to PBPs' active sites, forming stable acyl-enzyme complexes that irreversibly inhibit enzyme activity by covalently modifying key serine residues. This blocks cross-linking reactions required for proper cell wall assembly leading to bacterial lysis due to osmotic instability.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial penicillin-binding protein (transpeptidase) (None).